Page last updated: 2024-09-04

docetaxel anhydrous and Cancer of Paranasal Sinus

docetaxel anhydrous has been researched along with Cancer of Paranasal Sinus in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belot, A; CĂ©ruse, P; Cosmidis, A; Favrel, V; Fayette, J; Fuchsmann, C; Pommier, P; Poupart, M; Rabilloud, M; Ramade, A; Tartas, S; Zrounba, P1
Fukuda, S; Furusawa, J; Hatakeyama, H; Homma, A; Kano, S; Mizumachi, T; Nakamaru, Y; Onimaru, R; Sakashita, T; Shirato, H; Terasaka, S; Tsuchiya, K; Yasuda, K; Yoshida, D1
Hah, JH; Han, DH; Heo, DS; Keam, B; Kim, DW; Kim, DY; Kim, TM; Kwon, TK; Lee, SH; Ock, CY; Rhee, CS; Sung, MW; Won, TB; Wu, HG1
Chen, L; Chen, NX; Ma, L; Wang, JL; Yan, F; Zhang, XX1
Deguchi, K; Kurono, Y; Nagano, H; Yoshifuku, K1
Doi, T; Fuse, N; Hayashi, R; Kawashima, M; Ogino, T; Ohtsu, A; Okano, S; Tahara, M; Yoshino, T; Zenda, S1

Other Studies

6 other study(ies) available for docetaxel anhydrous and Cancer of Paranasal Sinus

ArticleYear
A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study.
    Anti-cancer drugs, 2014, Volume: 25, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Organ Sparing Treatments; Paranasal Sinus Neoplasms; Pyriform Sinus; Retrospective Studies; Taxoids

2014
Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A single institution experience.
    Auris, nasus, larynx, 2015, Volume: 42, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Cohort Studies; Docetaxel; Endoscopy; Ethmoid Sinus; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nasal Cavity; Neoplasm Staging; Nose Neoplasms; Organoplatinum Compounds; Otorhinolaryngologic Surgical Procedures; Paranasal Sinus Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids

2015
Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
    The Korean journal of internal medicine, 2016, Volume: 31, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Docetaxel; Eye; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Medical Records; Middle Aged; Nasal Cavity; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Nose Neoplasms; Organ Sparing Treatments; Paranasal Sinus Neoplasms; Proportional Hazards Models; Retrospective Studies; Risk Factors; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Taxoids; Time Factors; Treatment Outcome; Young Adult

2016
[Clinical analysis of multimodal treatment for orbital organ preservation in T4b squamous cell carcinoma of nasal cavity and paranasal sinuses].
    Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2016, Jul-07, Volume: 51, Issue:7

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; ErbB Receptors; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasal Cavity; Nose Neoplasms; Organ Sparing Treatments; Paranasal Sinus Neoplasms; Quality of Life; Radiation Injuries; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome

2016
Adenocarcinoma of the paranasal sinuses and nasal cavity with lung metastasis showing complete response to combination chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF): a case report.
    Auris, nasus, larynx, 2010, Volume: 37, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Nose Neoplasms; Paranasal Sinus Neoplasms; Taxoids; Treatment Outcome

2010
Induction chemotherapy with docetaxel, cisplatin and S-1 followed by proton beam therapy concurrent with cisplatin in patients with T4b nasal and sinonasal malignancies.
    Japanese journal of clinical oncology, 2012, Volume: 42, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Drug Combinations; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Nose Neoplasms; Oxonic Acid; Paranasal Sinus Neoplasms; Proton Therapy; Taxoids; Tegafur

2012